Study guide
11.4 Principles of Local, Regional & General Anaesthesia
Combined Medical Services Examination UPSC CMS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Logistics & Pattern
1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths
2 Chapter 2: General Medicine - Cardiology & Respiratory
2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism
3 Chapter 3: General Medicine - Gastroenterology & Hepatology
3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
4 Chapter 4: General Medicine - Nephrology & Endocrinology
4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction
5 Chapter 5: General Medicine - Neurology, Haematology & Infection
5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
6 Chapter 6: General Medicine - Emergency Medicine & Toxicology
6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology
7 Chapter 7: Paediatrics - Neonatology & Child Growth
7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones
8 Chapter 8: Paediatrics - Child Health & Nutrition
8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning
9 Chapter 9: Surgery - General Surgery, Wounds & Shock
9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery
10 Chapter 10: Surgery - Surgical Specialties I
10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi
11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia
11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease
12 Chapter 12: Obstetrics - Antenatal Care & Complications
12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management
13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH
13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care
14 Chapter 14: Gynaecology & Family Planning
14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods
15 Chapter 15: PSM - Epidemiology & Biostatistics
15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing
16 Chapter 16: PSM - Disease Epidemiology & Programmes
16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling
17 Chapter 17: PSM - Health Planning & Environmental Health
17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education
11.4 Principles of Local, Regional & General Anaesthesia
Key Takeaways Explain This Topic AI
Local Anaesthetics (LAs) are classified into Amides (Lidocaine, Bupivacaine, Ropivacaine - hepatic metabolism) and Esters (Procaine, Tetracaine, Cocaine - plasma cholinesterase metabolism), blocking voltage-gated Na+ channels.
Local Anaesthetic Systemic Toxicity (LAST) presents with early CNS excitation (tinnitus, metallic taste, seizures) progressing to cardiovascular collapse; 20% Intravenous Lipid Emulsion (Intralipid) is the specific antidote.
Spinal Anaesthesia (Subarachnoid Block) is performed at the L3-L4 or L4-L5 interspace below the conus medullaris (L1 in adults), penetrating dura mater into the subarachnoid space containing CSF.
The Triad of General Anaesthesia comprises Hypnosis/Unconsciousness, Analgesia, and Muscle Relaxation; pre-operative airway evaluation utilizes the Mallampati Classification (Classes I-IV) to anticipate difficult endotracheal intubation.
Malignant Hyperthermia is an autosomal dominant pharmacogenetic emergency triggered by volatile inhalational agents or Succinylcholine, presenting with unexplained hypercapnia, masseter rigidity, rapid temperature elevation, and rhabdomyolysis, treated immediately with IV Dantrolene.
Last updated: July 2026
Local Anaesthetics, Mechanism of Action & Systemic Toxicity (LAST)
Local Anaesthetics (LAs) reversibly block nerve impulse conduction along nerve axons by binding to the intracellular domain of voltage-gated sodium (Na+) channels , preventing Na+ influx and membrane depolarization.
Chemical Classification & Pharmacology
Local anaesthetic molecules consist of a lipophilic aromatic ring connected by an intermediate chain to a hydrophilic tertiary amine group. The nature of the intermediate linkage divides them into Amides and Esters :
Amide Local Anaesthetics (contain an 'i' in the prefix before -caine: L i docaine, Bup i vacaine, Rop i vacaine, Pr i locaine, Et i docaine):
Metabolized in the liver by cytochrome P450 enzymes.
Low potential for hypersensitivity/allergic reactions.
Ester Local Anaesthetics (Procaine, Chloroprocaine, Tetracaine, Cocaine, Benzocaine):
Metabolized in the plasma by plasma pseudocholinesterase (butyrylcholinesterase).
Higher risk of allergic reactions due to metabolic breakdown into para-aminobenzoic acid (PABA) .
Clinical Pharmacological Profiles
Local Anaesthetic Agent Class Onset of Action Duration of Action Max Single Dose (plain) Max Dose with Adrenaline (1:200,000) Primary Clinical Application
Lidocaine (Lignocaine) Amide Rapid (2-5 mins) Intermediate (1-2 hrs) 4.5 mg/kg (max 300 mg) 7.0 mg/kg (max 500 mg) Infiltration, nerve block, epidural, IV regional (Bier block), antiarrhythmic
Bupivacaine Amide Slow (15-20 mins) Long (4-8 hrs) 2.0 mg/kg (max 150 mg) 2.5 mg/kg (max 225 mg) Spinal, epidural, peripheral nerve block. High cardiotoxicity
Ropivacaine Amide Moderate (10-15 mins) Long (4-8 hrs) 3.0 mg/kg (max 200 mg) 3.5 mg/kg (max 250 mg) Epidural analgesia, nerve block (less cardiotoxic S-enantiomer of bupivacaine)
Prilocaine Amide Rapid Intermediate 6.0 mg/kg 8.0 mg/kg IV regional anaesthesia; causes Methemoglobinemia (treated with Methylene Blue)
Tetracaine Ester Slow Long 1.5 mg/kg 2.0 mg/kg Spinal anaesthesia, topical ophthalmic anaesthesia
Role of Adrenaline Additive : Adding Adrenaline (1:200,000 dilution = 5 mcg/mL) causes local vasoconstriction, which slows systemic vascular absorption, decreases peak blood concentration, prolongs duration of anaesthesia, and reduces surgical bleeding. Contraindicated in end-artery appendages (fingers, toes, penis, nose, ears) due to risk of ischemic gangrene.
Local Anaesthetic Systemic Toxicity (LAST)
LAST occurs due to accidental intravascular injection or rapid systemic absorption of excessive LA doses. Bupivacaine is particularly cardiotoxic due to slow dissociation from cardiac Na+ channels during diastole.
Clinical Sequence of LAST
Central Nervous System (CNS) Manifestations (Occurs first):
Early (Excitatory) : Circumoral numbness, metallic taste in mouth, tongue paresthesia, tinnitus, lightheadedness, restlessness, visual disturbances.
Late (Inhibitory) : Muscle twitching, generalized tonic-clonic seizures , sudden CNS depression, loss of consciousness, apnea.
Cardiovascular System (CVS) Manifestations (High mortality):
Hypertension and tachycardia progressing rapidly to severe myocardial depression , bradycardia, ventricular arrhythmias (ventricular fibrillation/tachycardia), and refractory cardiovascular collapse .
Emergency LAST Protocol (Lipid Rescue)
Stop LA Injection immediately and call for help.
Secure Airway : Hyperventilate with 100% oxygen (hypercapnia and acidosis worsen LA toxicity).
Control Seizures : Administer IV Benzodiazepines (Midazolam 1-2 mg or Lorazepam).
ANTIDOTE: 20% Intravenous Lipid Emulsion (Intralipid) :
Initial Bolus : 1.5 mL/kg IV over 1 minute (~100 mL for 70 kg adult).
Continuous Infusion : 0.25 mL/kg/min .
Mechanism ("Lipid Sink Theory"): Lipophilic LA molecules partition out of cardiac/brain tissue into the circulating lipid plasma phase.
- Neuraxial Blocks, General Anaesthesia & Airway Management
- Neuraxial Anaesthesia: Spinal vs Epidural
Neuraxial blocks involve injecting local anaesthetic around the spinal cord sheath to produce sensory, motor, and autonomic blockade of the lower body.
Clinical Parameter Spinal Anaesthesia (Subarachnoid Block) Epidural Anaesthesia
Anatomical Target Space Subarachnoid space (mixes directly with Cerebrospinal Fluid CSF) Epidural space (potential space between ligamentum flavum and dura mater)
Anatomical Level Below L1/L2 termination of spinal cord (usually L3-L4 or L4-L5 interspace ) Lumbar, thoracic, or cervical level (spinal cord absent/present)
Dura Mater Puncture Yes (dura and arachnoid punctured with fine needle - 25G/27G Quincke/Pencil-point) No (dura remains intact; Tuohy needle used to identify space via Loss of Resistance)
Volume & Dose of LA Very small volume ( 2.0 - 3.5 mL of 0.5% Hyperbaric Bupivacaine) Large volume ( 15 - 20 mL of Lidocaine or Bupivacaine)
Onset of Block Rapid (2 - 5 minutes) Slow (15 - 20 minutes)
Post-Dural Puncture Headache (PDPH) Risk present (occurs 24-48 hrs post-procedure due to CSF leak; treated with fluids, caffeine, or Epidural Blood Patch ) Absent unless accidental dural puncture occurs
Primary Clinical Uses Lower abdominal, pelvic, urological, and lower limb surgeries Labor analgesia, post-operative continuous catheter analgesia
Triad of General Anaesthesia (GA)
General Anaesthesia requires three core components: Hypnosis/Amnesia (inhalational/IV hypnotics), Analgesia (opioids), and Muscle Relaxation (neuromuscular blockers).
Airway Assessment: Mallampati Classification
Evaluates patient sitting upright, mouth open fully, tongue protruded without phonation:
Class I : Soft palate, fauces, uvula, anterior and posterior tonsillar pillars visible ( Easy intubation ).
Class II : Soft palate, fauces, and portion of uvula visible.
Class III : Soft palate and base of uvula visible.
Class IV : Only hard palate visible; soft palate completely hidden ( High risk of difficult intubation ).
- High-Yield Anaesthetic Emergencies
- 1. Malignant Hyperthermia (MH)
An autosomal dominant pharmacogenetic disorder of skeletal muscle calcium regulation caused by mutations in the Ryanodine Receptor gene (RYR1) . Triggered by volatile inhalational anesthetics (Halothane, Isoflurane, Sevoflurane) or depolarizing muscle relaxant Succinylcholine .
Pathophysiology : Uncontrolled efflux of calcium from sarcoplasmic reticulum causes sustained muscle contraction, hypermetabolism, hypercapnia, severe metabolic acidosis, hyperkalemia, hyperthermia (>40°C), and rhabdomyolysis.
Earliest Clinical Sign : Unexplained rapid rise in end-tidal CO2 ( ETCO2 ) and Masseter muscle spasm / rigidity after succinylcholine administration.
Specific Antidote : Intravenous Dantrolene Sodium (initial dose 2.5 mg/kg IV stat , repeated up to 10 mg/kg). Mechanism: Inhibits calcium release from rhabdomyocyte sarcoplasmic reticulum.
2. Aspiration Pneumonitis (Mendelson's Syndrome)
Chemical pneumonitis caused by pulmonary aspiration of acidic gastric contents (volume >25 mL, pH <2.5) during induction or emergence from GA. Prevented by Rapid Sequence Induction (RSI) using Sellick's maneuver (cricoid pressure compressing esophagus against C6 vertebra until endotracheal tube cuff is inflated).